MedDataX Logo

Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion

NCT ID: NCT05461027

Last Updated: 2024-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Kidney Cancer Central Kidney Tumours Renal Artery Occlusion cryoablation Urological surgery T1a tumours Cold sink effect Endovascular balloon clamping Renal hilum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult subject (≥18 years)
* Subject who has undergone cryoablation of a central kidney tumour with temporary occlusion of the renal artery by an endovascular balloon at the HUS during the period 01/01/2018 to 30/12/2021
* Subject who has not expressed his/her opposition, after information, to the re-use of his/her data for the purpose of this research.

Exclusion Criteria

* Subject having expressed his/her opposition to participate in the study
* Subject under legal protection, guardianship or curatorship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierre-Alexis AUTRUSSEAU, MD

Role: PRINCIPAL_INVESTIGATOR

Service d'Imagerie Interventionnelle - CHU de Strasbourg - France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'Imagerie Interventionnelle - CHU de Strasbourg - France

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8529

Identifier Type: -

Identifier Source: org_study_id